Reactivos e instrumentos para inmunología, biología celular y biología molecular.
 
> Tocilizumab [375823-41-9]

Tocilizumab [375823-41-9]

Imprimir Imprimir
Por favor conéctese

Referencia HY-P9917-1mg

embalaje : 1mg

Marca : MedChemExpress

Contact local distributor :


Teléfono : +1 850 650 7790

HTTP/1.1 200 OK Date: Sun, 28 Apr 2024 11:02:12 GMT Content-Type: text/html;charset=UTF-8 Transfer-Encoding: chunked Connection: keep-alive Set-Cookie: locale=es-ES; Max-Age=31536000; Expires=Mon, 28 Apr 2025 11:02:12 GMT; Path=/ Set-Cookie: locale=es-ES; Max-Age=31536000; Expires=Mon, 28 Apr 2025 11:02:12 GMT; Path=/ Set-Cookie: JSESSIONID=MGQwNWEzNTEtMTQ2ZS00NjFiLThlNDMtNzJiZjdmNzVjNmJi; Path=/; HttpOnly; SameSite=Lax CF-Cache-Status: DYNAMIC Server: cloudflare CF-RAY: 87b68f08dd5e029e-CDG Content-Encoding: gzip Tocilizumab (Anti-Human IL6R, Humanized Antibody) | IL-6R Neutralizing Antibody | MedChemExpress

Tocilizumab  (Synonyms: Anti-Human IL6R, Humanized Antibody)

Cat. No.: HY-P9917 Pureza: 98.00%
COA

Molarity Calculator

Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis. Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease).

Para uso exclusivo en investigación. No vendemos a pacientes.

Tocilizumab Estructura química

Tocilizumab Estructura química

No. CAS : 375823-41-9

Tamaño Precio Stock Cantidad
1 mg USD 280 En stock
5 mg USD 670 En stock
10 mg   Obtener un presupuesto  
50 mg   Obtener un presupuesto  

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 18 publication(s) in Google Scholar

Tocilizumab Related Antibodies

Top Publications Citing Use of Products

  • Actividad biológica

  • Pureza y Documentación

  • Referencias

  • Revisión del cliente

Descripciòn

Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis[1]. Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease)[4].

IC50 & Target[1][2]

IL-6

 

In Vitro

Tocilizumab (Anti-Human IL6R, Humanized Antibody) (1-100 ng/mL; 24 hours, 48 hours) inhibits the cell proliferation (growth rate) in a dose-dependent manner, growth rate by HACM is reduced almost completely by 100 ng/mL tocilizumab[2].
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (0.001-10,000 μg/ml; 2 days) inhibits Ba/F3-gp130-IL-6R cell proliferation stimulated with hIL-6 with an IC50 of 13.5 ng/ml[1].
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (1 μM; 6 hours) reduces the phosphorylation of STAT3 in vitro consistent with in vivo SAS cells[3].
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (1-5 μM; 24 hours) significantly reduces VEGF mRNA expression in SAS cells with serum-free medium[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Tocilizumab Related Antibodies

Cell Proliferation Assay[2]

Cell Line: Human-derived HARA-B cells
Concentration: 1 ng/mL, 10 ng/mL, and 100 ng/mL
Incubation Time: 24 hours, 48 hours
Result: Inhibited the IL-6R expressed on human-derived HARA-B cells.

Cell Cytotoxicity Assay[1]

Cell Line: Ba/F3-gp130-IL-6R cells
Concentration: 0.001–10000 μg/ml
Incubation Time: 2 days
Result: Inhibited Ba/F3-gp130-IL-6R cell proliferation.

Western Blot Analysis[3]

Cell Line: SAS cells
Concentration: 1 μM
Incubation Time: 6 hours
Result: Reduced the phosphorylation of STAT3.

RT-PCR[3]

Cell Line: SAS cells
Concentration: 1-5 μM
Incubation Time: 24 hours
Result: Reduced VEGF mRNA expression.
In Vivo

Tocilizumab (Anti-Human IL6R, Humanized Antibody) (intravenous injection; 1.0 mg/100 μL; twice a week, three weeks) decreases the volume of each metastatic focus in tocilizumab-injected mouse brains[2].
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (intraperitoneal injection;100 μg/mL, every 48 hours; 20days) suppresses OSCC progression and suppresses Tumor Angiogenesis[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: A brain metastasis model of lung tumor cells by inoculating HARA-B cells in nude mice[2]
Dosage: 1.0 mg/100 μL
Administration: Intravenous injection; 1.0 mg/100 μL; twice a week, three weeks
Result: Led the volume of each metastatic focus significantly smaller.
Animal Model: SCID mice with SAS cells[3]
Dosage: 100 μg/mL
Administration: Intraperitoneal injection;100 μg/mL; every 48 hours; 20days
Result: Suppressed the growth of advanced tumors.
Ensayo clínico
No. CAS
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Tocilizumab]
Envío

Shipping with dry ice.
Almacenamiento

Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación

Purity: 99.67%

COA (291 KB)

Instrucciones de manejo (2659 KB)
Referencias
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Tocilizumab Related Classifications

  • Calculadora de molaridad

  • Calculadora de dilución

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Tocilizumab375823-41-9Anti-Human IL6R, Humanized AntibodyInterleukin RelatedILantibodyIL-6RNeutralizingrheumatoidarthritisSARS-CoV-2coronavirus diseaserespiratory failuredyspnoeaCOVID-19Inhibitorinhibitorinhibit

Productos vistos recientemente:

Consulta en línea

Your information is safe with us. * Required Fields.

Nombre del producto

  

Salutation

Nombre del solicitante *

 

Direcciòn del E-mail *

Número de teléfono *

 

Nombre de la Organizaciòn *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Consulta para venta a granel

Inquiry Information

Nombre del producto:
Tocilizumab
Cat. No.:
HY-P9917
Cantidad:
MCE Japan Authorized Agent:

Revisión del cliente

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Nombre del producto

  

Lot #

Nombre del solicitante *

 

Direcciòn del E-mail *

Número de teléfono

 

Department *

Nombre de la Organizaciòn *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

Usted podría estar interesado también en los siguientes productos:



Referencia
Descripción
Cond.
Precio Sin IVA
HY-100461-1mg
C29 [363600-92-4]
 1mg 
A10970-1
Anti-TMPRSS13 Antibody Picoband™
 100ug/vial